Clinical Trials
4 trialsNCT04395612 2021-05-21
CQGOG0101
Chongqing University Cancer Hospital
Phase 2 Unknown
NCT01253668 2021-04-13
Brivanib Metastatic Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine
Phase 2 Terminated
NCT01367275 2020-09-03
Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03895788 2019-03-29
A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer
Hunan Cancer Hospital
Phase 1 Unknown